Filing Details
- Accession Number:
- 0001735276-21-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-15 16:03:27
- Reporting Period:
- 2021-01-13
- Accepted Time:
- 2021-01-15 16:03:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1620743 | Laurie Keating | 675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142 | Evp, Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-13 | 3,027 | $77.40 | 5,261 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-01-13 | 6,000 | $85.00 | 11,261 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-13 | 5,000 | $169.00 | 6,261 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-13 | 3,000 | $170.00 | 3,261 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-13 | 1,027 | $174.00 | 2,234 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-13 | 3,027 | $0.00 | 3,027 | $77.40 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-13 | 6,000 | $0.00 | 6,000 | $85.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,164 | 2024-09-22 | No | 4 | M | Direct | |
| 19,000 | 2029-02-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 434 | Indirect | by Managed Account |
Footnotes
- All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.
- Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Billionaire Hedge Funds
